These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31216439)

  • 1. A brief history of antibody-based therapy.
    Alpaugh M; Cicchetti F
    Neurobiol Dis; 2019 Oct; 130():104504. PubMed ID: 31216439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active and passive immunotherapy for neurodegenerative disorders.
    Brody DL; Holtzman DM
    Annu Rev Neurosci; 2008; 31():175-93. PubMed ID: 18352830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active and passive immunization for cancer.
    Baxter D
    Hum Vaccin Immunother; 2014; 10(7):2123-9. PubMed ID: 25424829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Active and passive immunization: 1991 status].
    Herzog C
    Ther Umsch; 1991 Apr; 48(4):232-44. PubMed ID: 1858065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal immunization to prevent infectious diseases in the neonate or infant.
    Insel RA; Amstey M; Woodin K; Pichichero M
    Int J Technol Assess Health Care; 1994; 10(1):143-53. PubMed ID: 8157447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy against amyloid pathology in Alzheimer's disease.
    Galimberti D; Ghezzi L; Scarpini E
    J Neurol Sci; 2013 Oct; 333(1-2):50-4. PubMed ID: 23299047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches.
    Kumar NN; Pizzo ME; Nehra G; Wilken-Resman B; Boroumand S; Thorne RG
    Bioconjug Chem; 2018 Dec; 29(12):3937-3966. PubMed ID: 30265523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming the susceptibility gap between maternal antibody disappearance and auto-antibody production.
    Yosipovich R; Aizenshtein E; Shadmon R; Krispel S; Shuster E; Pitcovski J
    Vaccine; 2015 Jan; 33(3):472-8. PubMed ID: 25444785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer therapy for neurodegenerative disorders.
    Feigin A; Eidelberg D
    Mov Disord; 2007 Jul; 22(9):1223-8; quiz 1369. PubMed ID: 17393533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsulated cellular implants for recombinant protein delivery and therapeutic modulation of the immune system.
    Lathuilière A; Mach N; Schneider BL
    Int J Mol Sci; 2015 May; 16(5):10578-600. PubMed ID: 26006227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Antibody Fragments for Neurodegenerative Diseases.
    Manoutcharian K; Perez-Garmendia R; Gevorkian G
    Curr Neuropharmacol; 2017; 15(5):779-788. PubMed ID: 27697033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing sexual transmission of HSV and HIV: the challenge for active and passive immunization of mucosal surfaces.
    Zeitlin L; Palmer C; Whaley KJ
    Biotechnol Genet Eng Rev; 2002; 19():121-38. PubMed ID: 12520875
    [No Abstract]   [Full Text] [Related]  

  • 13. Passive and active immunization strategies against Clostridium difficile infections: state of the art.
    Mizrahi A; Collignon A; Péchiné S
    Anaerobe; 2014 Dec; 30():210-9. PubMed ID: 25079668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focus issue: signals to neurodegeneration.
    Wong W
    Sci Signal; 2009 Jul; 2(80):eg9. PubMed ID: 19622828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive and active immunoprophylaxis of hepatitis B.
    Seeff LB; Koff RS
    Gastroenterology; 1984 May; 86(5 Pt 1):958-81. PubMed ID: 6231210
    [No Abstract]   [Full Text] [Related]  

  • 16. Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine.
    McConnell MJ; Pachón J
    Vaccine; 2010 Dec; 29(1):1-5. PubMed ID: 21044668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we vaccinate against atherosclerosis?
    Chyu KY; Shah PK
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):77-82. PubMed ID: 24038015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Therapy for Neurodegenerative Diseases.
    Sudhakar V; Richardson RM
    Neurotherapeutics; 2019 Jan; 16(1):166-175. PubMed ID: 30542906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An augmented passive immune therapy to treat fulminant bacterial infections.
    Rajam G; Sampson J; Carlone GM; Ades EW
    Recent Pat Antiinfect Drug Discov; 2010 Jun; 5(2):157-67. PubMed ID: 20370679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases.
    Duarte-Neves J; Pereira de Almeida L; Cavadas C
    Neurobiol Dis; 2016 Nov; 95():210-24. PubMed ID: 27461050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.